Day: October 7, 2024

Subsea 7 S.A. has received notification of transactions in its shares by primary insiders. Please see the attachment for details. This information is pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.AttachmentCSSF Filing Stuart Fitzgerald 20241007

U.S. Supreme Court denied United Therapeutics’ petition to appeal rulings that found all claims of U.S. Patent No. 10,716,793 (‘793 Patent) were invalid Decisions that Liquidia does not infringe any valid claims of the three patents originally asserted by United Therapeutics are now final and not subject to further appealMORRISVILLE, N.C., Oct. 07, 2024 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, today announced that the United States Supreme Court has rejected United Therapeutics’ (UTHR) petition for a writ of certiorari, which requested permission to appeal prior decisions which found that all claims of  U.S. Patent No. 10,716,793 (‘793 Patent) are unpatentable due to prior art. As a result, the decision...

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”) extended and increased total commitments for its revolving credit facility (the “Facility”) for Prospect Capital Funding LLC, a GAAP consolidated subsidiary of Prospect, with the most recent upsize in the quarter ended September 30, 2024. Facility commitments currently aggregate $2.1215 billion from a group of 48 banks (with a combined asset base of over $7.5 trillion), which Prospect considers the largest number of lenders to any business development company’s credit facility. The Facility includes an accordion feature allowing aggregate commitments to be increased up to $2.25 billion. The Facility term comprises five years from the initial closing, with a maturity of June 28, 2029. The Facility has a revolving period of four years...

VANCOUVER, British Columbia, Oct. 07, 2024 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) confirms that the Bomboré mining permit is valid, and that the government of Burkina Faso has no intention to withdraw or revoke the Bomboré mining permit. On October 5, 2024, the President of Burkina Faso, President Traore, spoke on Radio Burkina about several topics including corruption, transport, agriculture and mining. Importantly, with respect to security, the President spoke about the significant progress that has been made regaining territory lost to terrorist groups in the north and east of Burkina Faso, and he sees further progress by the end of 2025. Following the radio broadcast, there has been concerns in the mining sector about the government possibly withdrawing mining permits. The...

86% of Utilities Identify Artificial Intelligence and Machine Learning as Crucial for Addressing Operational Challenges Amid Energy TransitionEnergy Demand by the NumbersThe graphic highlights what’s driving changes in energy demand from different categories.LIBERTY LAKE, Wash., Oct. 07, 2024 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, today released its 2024 Resourcefulness Insight Report (“the report”) that explores the current trends and future expectations of artificial intelligence (AI) and machine learning (ML) on utility operations and strategies. The report, Exploring AI for Utilities: The Promise and Challenges of Artificial Intelligence, summarizes key findings from 600 utility executives from the United States, Canada,...

Affiliates of Murchinson, 3i LP, and existing senior debt holder, Oramed Pharmaceuticals, Inc. (“Oramed”), are expected to participate in the $50 million convertible note offering, which is expected to close on or about October 7, 2024. The offering involves a refinancing and restructuring of existing debt and is expected to position Scilex for sustainable, long-term growth, as part of its multi-year plan to transform into a potential global and leading non-opioid pain management company. Scilex will receive from Oramed in consideration for the newly issued convertible note issued to Oramed an exchange and reduction of the principal balance under the Company’s existing Senior Secured Promissory Note with Oramed (the “Oramed Note”). Over the past 12 months, Scilex has aggressively addressed and restructured the debt on our balance sheet...

BMF-219 is an investigational oral covalent menin inhibitor developed to regenerate insulin-producing beta cellsTwo trial-in-progress oral presentations to feature Phase II study design of oral covalent menin inhibitor BMF-219 in patients with type 2 diabetes (COVALENT-111) and in patients with type 1 diabetes (COVALENT-112) One late breaker oral presentation to highlight two case studies assessing BMF-219 in persons with poorly controlled severe insulin-deficient (SIDD) type 2 diabetesREDWOOD CITY, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent small molecules to treat and improve the lives of patients with diabetes, obesity, and genetically defined cancers, today announced the attendance...

DENVER, Oct. 07, 2024 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the premier luxury vacation club, today announced the promotion of Michael Arthur to Chief Financial Officer. Robert Kaiden, the current CFO, has planned to transition out of the role effective November 8, 2024. The Company also named three new members to its Board of Directors. Mr. Arthur joined Inspirato in February 2023 and has served as Senior Vice President of Finance, overseeing Corporate Finance, FP&A and Treasury. Prior to Inspirato, he spent more than 10 years in finance, accounting, and corporate strategy roles at PwC and VF Corporation. He will replace current CFO, Robert Kaiden, effective November 8, 2024. “We are immensely grateful to Robert for his leadership and contributions during a critical period...